- Yu Liu
(State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Jianjun Zhang
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Lin Li
(State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Guangliang Yin
(Beijing Genomics Institute)
- Jianhua Zhang
(Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center)
- Shan Zheng
(Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Hannah Cheung
(The University of Texas MD Anderson Cancer Center)
- Ning Wu
(Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Ning Lu
(Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Xizeng Mao
(Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center)
- Longhai Yang
(Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Jiexin Zhang
(The University of Texas MD Anderson Cancer Center)
- Li Zhang
(Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Sahil Seth
(Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center)
- Huang Chen
(State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Xingzhi Song
(Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center)
- Kan Liu
(Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Yongqiang Xie
(Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Lina Zhou
(Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Chuanduo Zhao
(Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Naijun Han
(State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Wenting Chen
(State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Susu Zhang
(State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Longyun Chen
(Beijing Genomics Institute)
- Wenjun Cai
(Beijing Genomics Institute)
- Lin Li
(Beijing Genomics Institute)
- Miaozhong Shen
(Beijing Genomics Institute)
- Ningzhi Xu
(State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Shujun Cheng
(State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Huanming Yang
(Beijing Genomics Institute)
- J. Jack Lee
(The University of Texas MD Anderson Cancer Center)
- Arlene Correa
(The University of Texas MD Anderson Cancer Center)
- Junya Fujimoto
(The University of Texas MD Anderson Cancer Center)
- Carmen Behrens
(The University of Texas MD Anderson Cancer Center)
- Chi-Wan Chow
(The University of Texas MD Anderson Cancer Center)
- William N. William
(The University of Texas MD Anderson Cancer Center)
- John V. Heymach
(The University of Texas MD Anderson Cancer Center)
- Waun Ki Hong
(The University of Texas MD Anderson Cancer Center)
- Stephen Swisher
(The University of Texas MD Anderson Cancer Center)
- Ignacio I. Wistuba
(The University of Texas MD Anderson Cancer Center)
- Jun Wang
(Beijing Genomics Institute
University of Copenhagen)
- Dongmei Lin
(Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- Xiangyang Liu
(Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)
- P. Andrew Futreal
(The University of Texas MD Anderson Cancer Center
Honorary Faculty, Wellcome Trust Sanger Institute)
- Yanning Gao
(State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences)